Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Bullboard Posts
Comment by EbbFlow88on Mar 16, 2018 12:10pm
100 Views
Post# 27728034

RE:digitel low canadian dollar

RE:digitel low canadian dollarI wouldn't worry too much about disclosures. Let management focus on the important things.

The big question that the big investors are asking is "was the performance in Q1 and Q2 in 2016 a one time thing, or is this a sustainable business with serious prospects of growth?" At 40M market cap it wont get much attention. If it shows growth again and regains its 20%+ sales growth and fantastic margins that will be the catalyst. 

Can the IR be better? yeah, but in the end it's not whats going to add shareholder value. Only results will. So, lets focus on that. Juvente and functional drink should and hopefully will add a material boost to operations, setting up a great stage for cholesterol and other products.We as retail investors have a huge advantage in investing in this company at these prices.
Bullboard Posts